On Nov. 19, 2015, AquaBounty Technologies announced the FDA has approved the Company’s New Animal Drug Application for the production, sale, and consumption of its AquAdvantageﾮ Salmon, an Atlantic salmon that has been genetically enhanced to reach market size in less time than conventional farmed Atlantic salmon. The transgenic fast-growing salmon were created in 1989.